Our Postdoctoral Fellowships (formerly called Senior Research Training Fellowships) are awarded to outstanding postdoctoral candidates from the nursing or allied health professions, and are intended to enable you to embark on an independent career in academic stroke research.
The Stroke Priority Setting Partnership is being guided by a Steering Group. Members include people affected by stroke, health and social care professionals, and those in supporting roles. Where two people are named for one organisation, they are sharing one place.
This study will explore whether an existing therapy, Solution Focused Brief Therapy (SFBT), can be used for people with aphasia. Information will also be collected to design a future large-scale trial evaluating this approach.
As part of our research programme, we fund exceptional candidates from stroke professional backgrounds to our prestigious Postgraduate and Postdoctoral Fellowship positions. Meet our new fellows for 2017.
This research can improve a camera-based computer programme so it can be used by health care professionals and stroke survivors to help in physical rehabilitation.
The European Stroke Organisation Conference (ESOC) 2017 is currently on from 16-18 May in Prague, Czech Republic.
Thousands of people are at risk of stroke because they fail to recognise the signs of a Transient Ischaemic Attack (TIA, also known as a mini-stroke), according to the findings of a new poll launched today on World Stroke Day (29 October 2012).
Our support for research has built a community of stroke researchers in the UK, and continues to change the lives of those affected by stroke.
The UK Stroke Forum 2017 took place this week at the ACC in Liverpool. The event showcases what's hot in the UK stroke community, including the latest research, and how stroke professionals can get involved in research.
The European Stroke Organisation Conference (ESOC) 2018 is currently on from 16-18 May in Gothenburg, Sweden. The first day of ESOC included some truly inspiring scientific sessions, including the WAKE-UP trial, RIGHT-2 trial and CROMIS-2 trials.